Adverse drug reactions linked to fidaxomicin: insights from a retrospective analysis of the FAERS database
While fidaxomicin is generally well-tolerated, our study identified rare but serious neuropsychiatric and cardiovascular ADRs. Further research is needed to investigate these effects and ensure informed, shared decision-making between prescribers and patients.
Authors
- Douglas G. Adler (ORCID: https://orcid.org/0000-0003-3214-6285)
- Parth Patel (ORCID: https://orcid.org/0009-0004-5481-5464)
- Mohamad Ayman Ebrahim
Institutions
- Porter Adventist Hospital (US)
- Saint Joseph Hospital (US)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1080/14740338.2025.2487142
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00